SELLAS Life Sciences (SLS) Consolidated Net Income (2020 - 2023)
Historic Consolidated Net Income for SELLAS Life Sciences (SLS) over the last 7 years, with Q4 2023 value amounting to -$8.2 million.
- SELLAS Life Sciences' Consolidated Net Income rose 1343.43% to -$8.2 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$8.2 million, marking a year-over-year increase of 7910.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 830.97% up from last year.
- Latest data reveals that SELLAS Life Sciences reported Consolidated Net Income of -$8.2 million as of Q4 2023, which was up 1343.43% from -$9.4 million recorded in Q3 2023.
- SELLAS Life Sciences' Consolidated Net Income's 5-year high stood at -$2.2 million during Q1 2021, with a 5-year trough of -$16.7 million in Q1 2022.
- In the last 4 years, SELLAS Life Sciences' Consolidated Net Income had a median value of -$7.7 million in 2022 and averaged -$7.6 million.
- Its Consolidated Net Income has fluctuated over the past 5 years, first surged by 4475.89% in 2021, then plummeted by 64543.43% in 2022.
- SELLAS Life Sciences' Consolidated Net Income (Quarter) stood at -$4.2 million in 2020, then tumbled by 179.37% to -$11.6 million in 2021, then grew by 18.7% to -$9.4 million in 2022, then grew by 13.43% to -$8.2 million in 2023.
- Its last three reported values are -$8.2 million in Q4 2023, -$9.4 million for Q3 2023, and -$9.0 million during Q2 2023.